Although the adulteration of dietary supplement products is not new, the recall of the prescription form of sibutramine and the growth in the black market trade of this weight-loss ingredient, as well as adulteration problems associated with muscle-building and male sexual enhancement supplements, have fueled increased regulatory action on the part of FDA in recent months.
The issue of product adulteration and its potential fallout could impact every part of the dietary supplements sector, and the FDA and dietary supplement industry associations are working together to determine the best ways to stem the tide of adulterated products.
